Company / Operating Margin
Immunome Inc. Operating Margin History
FY2023-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Operating Margin
-3228.8%
FY2025
5-year range
-3228.8% / -263.2%
FY2023-FY2025
Trend
-313.2%
vs FY2024
Sector context
#127 of 135
Health Care
What the data says
Operating Margin changed -313% YoY in FY2025, a notable deviation from the 2-year average annual change of -255%.
Based on SEC 10-K filings.
-3228.8% in FY2025.
Declined from -263.2% to -3228.8% over the past 2 years.
Health Care sector context is included.
Operating Margin over time
Growth rates
- 3-Year Change
- -
- 5-Year Change
- -
- 10-Year Change
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 135This company -3228.8% Sector average -774.4%
▼
-316.9% below sector average
Key checks
Key Insights
- In FY2025, operating margin decreased 313.2% year-over-year.
- Currently 2454.4pp below the Health Care sector average.
Company context
Key Data Points
- Altman Z-Score 4.19 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Operating MarginValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -3228.8% | -313.2% |
| FY2024 | -781.4% | -196.8% |
| FY2023 | -263.2% | - |
| FY2022 | - | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026